1-6 of 6
Hongwei Xue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of bmetl regimen (Orelabrutinib plus Semustine, Temozolomide and Lenalidomide) with subsequent maintenance treatment in elderly/frail patients with CNSL

Free
Yawen Wang, Hongwei Xue, Wei Song, Shuxin Xiao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7228.
https://doi.org/10.1182/blood-2025-7228
Published: 2025
Journal Articles

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Free
Wei Li Zhao, Jun Zhu, Pengpeng Xu, Yuqin Song, Jianzhen Shen, Qingqing Cai, Hui Zhou, Liling Zhang, Ying Xiang, Xiuhua Sun, Wei Yang, Zhihua Yao, Hongmei Jing, Shujuan Wen, Jie Jin, Hongwei Xue, Hong Cen, Kaiyang Ding, Zhengming Jin, Lihong Liu, Xiaojing Xing, Lanfang Li, Ming Hou, Lin LIU, Mingzhi Zhang, Wenyu Li, Ou Bai, Ru Feng, Zunmin Zhu, Huijing Wu, Liping Su, Li Gao, Fei Li, Wenrong Huang, Peng Liu, Xiaojing Yan, Ying Zhao, Hang Su, Xielan Zhao, Rong FU, Hong Liu, Wenyu Shi
Journal: Blood
Blood (2025) 146 (Supplement 1): 475.
https://doi.org/10.1182/blood-2025-475
Published: 2025
Journal Articles

First evaluation of novel cmoep (Liposomal Mitoxantrone-Based Chemotherapy) in front-line peripheral T-cell lymphoma: The compass Phase II study

Free
Jingwei Yu, Jiesong Wang, Hongwei Xue, Zhengzi Qian, Lihua Qiu, Jin Zhang, Yan Huang, Lintao Bi, Lanfang Li, Huilai Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3647.
https://doi.org/10.1182/blood-2025-3647
Published: 2025
Journal Articles

Tislelizumab in Combination with Chidamide, Prednisone, Etoposide, and Lenalidomide Followed By Autologous Stem Cell Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma

Free
Yawen Wang, Hongwei Xue
Journal: Blood
Blood (2024) 144 (Supplement 1): 6369.
https://doi.org/10.1182/blood-2024-201456
Published: 2024
Journal Articles

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Free
Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 1690.
https://doi.org/10.1182/blood-2023-188245
Published: 2023
Journal Articles

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Free
Xinhua Wang, MD PhD, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhiyuan Zhou, Xiaolong Wu, Li Tian, Wencai Li, Hongwei Xue, Jinghua Wang, Liqun Zou, Liping Su, Yi Lu, Yanzhen Guo, Ken H. Young, Mingzhi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 463.
https://doi.org/10.1182/blood-2019-127811
Published: 2019